AURINIA PHARMACEUTICALS INC. Chart calendar Aurinia Pharmaceuticals Inc.
d2.QXknW_kwVuE70HAE48RV2DJ9GKiJDovK4li58xhdBWA.MTBQOKl9MrBXtAp1rK4-lH8oKO_IftKZqi_utyguaxUKLm0xqQE4jQqyJQ~bd563dcb333a626f892b9c6f9c37b90b
Upcoming events on Aurinia Pharmaceuticals Inc.
Past events on Aurinia Pharmaceuticals Inc.
| 14/07/2024 | Wainwright Virtual Kidney Conference |
| 08/07/2024 | Leerink Partners Therapeutics I&I and Metabolism Forum |
| 14/06/2024 17:00 | Annual General Meeting |
| 11/06/2024 | European Alliance of Associations for Rheumatology Congress |
| 05/06/2024 13:00 | Jefferies Global Healthcare Conference |
| 15/05/2024 15:00 | RBC Capital Markets Global Healthcare Conference |
| 13/05/2024 | National Kidney Foundation Spring Clinical Meeting |
| 10/05/2024 20:45 | Clinical Rheumatology Congress - Gabriel Contreras |
| 10/05/2024 20:45 | Clinical Rheumatology Congress - Maria Dall’Era |
| 02/05/2024 13:30 | Q1 2024 Earnings Call |
| 02/05/2024 11:00 | Q1 2024 Earnings Release |
| 16/04/2024 21:00 | Bloom Burton & Co. Healthcare Investor Conference |
| 12/03/2024 12:40 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 18:30 | TD Cowen Health Care Conference |
| 15/02/2024 13:30 | Q4 2023 Earnings Call |
| 15/02/2024 11:00 | Q4 2023 Earnings Release |
| 14/11/2023 17:00 | American College of Rheumatology Conference - Samir Parikh |
| 14/11/2023 17:00 | American College of Rheumatology Conference - Emily Littlejoh |
| 13/11/2023 17:00 | American College of Rheumatology Conference - Gabriel Contreras |
| 12/11/2023 22:00 | American College of Rheumatology Conference - Maria Dall’Era |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,32 0,35 -10.13% | 50,1 11,2 347.29% | 45,6 44,2 3.08% | 134 133 0.41% | 176 176 -0.03% | 227 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -76,5 -76,6 0.18% | -34,7 -33,1 -4.93% | 40,9 |
|
EBIT Million USD | Released Forecast Spread | -82,6 -76,3 -8.24% | -104 -115 8.92% | -181 -182 0.94% | -111 -122 8.79% | -91,7 -85,8 -6.89% | 11,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -124 -69,5 -78.11% | -103 -107 3.54% | -180 -183 1.57% | -106 -120 11.35% | -77,5 -75,0 -3.24% | 9,03 |
|
Net income Million USD | Released Forecast Spread | -124 -67,6 -83.23% | -103 -104 1.35% | -181 -182 0.4% | -108 -121 10.28% | -78,0 -74,8 -4.31% | 9,08 |
|
EPS USD | Released Forecast Spread | -1,33 -0,72 -83.77% | -0,87 -0,90 3.81% | -1,40 -1,42 1.41% | -0,76 -0,85 10.59% | -0,54 -0,52 -3.51% | 0,06 |
| Announcement Date | 05/03/20 | 24/02/21 | 28/02/22 | 28/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21,6 19,2 12.42% | 28,2 27,0 4.24% | 55,8 36,4 53.2% | 28,4 28,8 -1.33% | 34,4 28,1 22.36% | 41,5 37,5 10.64% | 54,5 38,5 41.58% | 45,1 45,2 -0.14% | 50,3 47,1 6.86% | 54,7 | 55,2 | 66,8 |
|
EBITDA Million USD | Released Forecast Spread | -24,9 -24,0 -3.93% | -0,37 -20,0 98.15% | -21,0 -22,9 8.39% | -19,5 -20,7 5.83% | -3,28 -14,2 76.89% | 1,00 -15,4 106.49% | -13,0 -11,3 -14.66% | -2,67 -6,00 55.52% | 7,20 | 7,00 | 16,5 | |
|
EBIT Million USD | Released Forecast Spread | -37,9 -36,3 -4.34% | -36,0 -30,3 -18.93% | -9,50 -25,4 62.63% | -28,1 -39,1 28.05% | -29,6 -31,9 7.22% | -16,2 -28,4 43.16% | -16,3 -25,9 37.29% | -29,7 -23,4 -27.06% | -13,3 -18,2 27.35% | 1,04 | 4,25 | 19,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,6 -37,1 -1.49% | -35,5 -30,1 -18.11% | -8,04 -25,2 68.08% | -25,2 -39,0 35.33% | -25,8 -30,9 16.58% | -12,1 -26,8 54.71% | -13,1 -23,9 44.91% | -26,4 -23,9 -10.69% | -10,0 -16,5 39.34% | 1,26 | 4,06 | 15,4 |
|
Net income Million USD | Released Forecast Spread | -37,6 -36,9 -1.9% | -35,5 -30,9 -14.86% | -8,99 -27,0 66.71% | -26,0 -38,7 32.7% | -26,2 -31,6 17.16% | -11,5 -26,9 57.32% | -13,4 -24,3 44.56% | -26,9 -23,6 -14.01% | -10,7 -18,7 42.4% | 1,46 | 3,89 | 15,3 |
|
EPS USD | Released Forecast Spread | -0,27 -0,27 -1.07% | -0,25 -0,22 -12.9% | -0,06 -0,19 68.96% | -0,18 -0,27 34.03% | -0,18 -0,22 18.71% | -0,08 -0,19 57.25% | -0,09 -0,17 46.15% | -0,19 -0,16 -16.33% | -0,07 -0,14 48.78% | 0,01 | 0,03 | 0,11 |
| Announcement Date | 10/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | 02/05/24 | - | - | - |
More events
Past sector events for Aurinia Pharmaceuticals Inc.
| 11/07/2024 21:00 | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 08/07/2024 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/07/2024 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 04/07/2024 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 06/06/2024 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 06/06/2024 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
